Reason for request
Inclusion on the list of products reimbursed by National Insurance and for hospital use in the extension of indication: "Symptomatic relief in the treatment of ankylosing spondylitis".
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités est important dans l'extension d’indication : soulagement des symptômes dans le traitement de la spondylarthrite ankylosante.
|
Clinical Added Value
| no clinical added value |
Dans le traitement de la spondylarthrite ankylosante, CELEBREX® n'apporte pas d'amélioration du service médical rendu (V) par rapport aux autres AINS.
|
eNq1mFFv2jAQx9/5FFHeSQijbTYFqo21G9KqMVq0aS+VSY5i5trp2Qa6Tz+HUI1Ojroa/Bjb+d/F9/fPp2Tnm3sWrAAlFbwfJlEnDIDnoqD8rh9Oby7baXg+aGVLsiJ7y86iTpR0wyBnRMp+WM1GMyBcRj+uvnwE8z5gOGgFmZgtIVfP1mlFWfSZyMUVKas1QbYStAjuQS1E0Q9LrbajQSYVmiwGa4G/ZElyyOLdyP7s8ra3P57Fldh/qGoJ+IXwO6socCfNXCMCV0Oi4E7gY0O+b5y0qZyAFBpzGBO1GKNY0QIKa4g5YRKcgszXxTXgioGqgljF42V+L53EyZJsJvAwsif93swO1Ua1O+3kLO12kt5pL0mTxCkU7m2VvQrmI+L8Nj3rpWk3Bh7nwGCGsHGszVigIsxTVagcPjeWpzgIDy9Wv6CyZOQxWsrSdasIEjMNaI6/vw+pvuAGDZCY2bN/9LlmLH5l1tMdLjxlXNFoKDRXDdS4nLhuxFBwBZvmirqBTm12XqQgjyf7W3A75Md6xmjuijQDHQ1STSejZqIdEwYfiIQp+qPBd8oLsZbHp8x+VT1lX25BaRUtsUhuu2/T0+TkxPkQ/TQWarhhLjSKEmLDHyoPwcqIz8WhQDGutEs9efJodtz2OSInDBo6nbYjW4wPnxozb073d4rqCavop4sbV3t804CP19tHqzQt+k+FdeOuD5gbLzbm/Xpn1wfcSwus0Q6OhVKlfBfH6/U6WhDZlsTsUjTHo4N97y7114B7ubDrBqaGo6fUZ/Wt97oKuR60l670Q9vU3fu7dtgaQ6GGA2pRM9kbOUcXx4fx3x7VW9rjZ/TwF2bbTxJFBffV5+iZVfEg/Juy8ks0fPg6n9OG/yGNtszi+l/MoJXF1X+YQesPPNXlKA==
0GwTKLHgBzaDJRAm
